Order Article Reprints

Dubler S, Turan ÖC, Schmidt KD, rath P-m, Verhasselt H-L, Maier S, Skarabis A, Brenner T, Herbstreit F. Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience. Diagnostics. 2022; 12(12):3049. https://doi.org/10.3390/diagnostics12123049

Dubler, Simon, Ömer Can Turan, Karsten Daniel Schmidt, Peter-michael rath, Hedda-Luise Verhasselt, Sandra Maier, Annabell Skarabis, Thorsten Brenner, and Frank Herbstreit. 2022. "Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience" Diagnostics 12, no. 12: 3049. https://doi.org/10.3390/diagnostics12123049

Dubler, S., Turan, Ö. C., Schmidt, K. D., rath, P.-m., Verhasselt, H.-L., Maier, S., Skarabis, A., Brenner, T., & Herbstreit, F. (2022). Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience. Diagnostics, 12(12), 3049. https://doi.org/10.3390/diagnostics12123049